Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PFE - Arbutus: IP Drama With High Stakes

PFE - Arbutus: IP Drama With High Stakes

Pfizer Inc.

2025-09-15 16:27:30 ET

Investment Thesis

Arbutus Biopharma, headquartered in Warminster, Pennsylvania, is a clinical-stage biopharmaceutical company . Its main focus is on expertise in liposomal drug delivery and RNA interference. Arbutus owns a broad and diverse patent portfolio covering various functional aspects of lipid nanoparticle (LNP) technology. LNP technology is mainly known as being used in mRNA-based COVID-19 vaccines made by Moderna and Pfizer/BioNTech . In addition, Arbutus is also developing drugs for chronic hepatitis B virus infection (HBV)....

For further details see:

Arbutus: IP Drama With High Stakes

Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...